ライフサイエンスコーパス: cholangiopancreatography

1 es, 7 colonoscopies, 2 endoscopic retrograde cholangiopancreatographies).

2 er endoscopies, and 58 endoscopic retrograde cholangiopancreatographies).

3 cture was confirmed by endoscopic retrograde cholangiopancreatography.

4 iliary stent placed by endoscopic retrograde cholangiopancreatography.

5 ning biliary access at endoscopic retrograde cholangiopancreatography.

6 -Science Conference on endoscopic retrograde cholangiopancreatography.

7 tis in comparison with endoscopic retrograde cholangiopancreatography.

8 uces the incidence of pancreatitis following cholangiopancreatography.

9 iatric experience with endoscopic retrograde cholangiopancreatography.

10 hose at helical CT and endoscopic retrograde cholangiopancreatography.

11 cells obtained during endoscopic retrograde cholangiopancreatography.

12 d tissue sampling with endoscopic retrograde cholangiopancreatography.

13 on the advisability of endoscopic retrograde cholangiopancreatography.

14 om tissue extracted by endoscopic retrograde cholangiopancreatography.

15 pcSEMS (n = 71) during endoscopic retrograde cholangiopancreatography.

16 oth endosonography and endoscopic retrograde cholangiopancreatography.

17 The first description of magnetic resonance cholangiopancreatography, a new noninvasive imaging stud

18 hemoprevention of post-endoscopic retrograde cholangiopancreatography acute pancreatitis and enteral

19 hemoprevention of post-endoscopic retrograde cholangiopancreatography acute pancreatitis remains unpr

20 ET/CT, MDCT, and MR imaging combined with MR cholangiopancreatography, all of which were evaluated in

21 Specificities for MR cholangiopancreatography alone and for MR cholangiopancr

22 yields higher diagnostic performance than MR cholangiopancreatography alone.

23 ct cholangiography (45 endoscopic retrograde cholangiopancreatography and 1 percutaneous transhepatic

24 Endoscopic retrograde cholangiopancreatography and balloon trawling of the int

25 tomy was defined using endoscopic retrograde cholangiopancreatography and categorized as a normal duc

26 Magnetic resonance cholangiopancreatography and endoscopic ultrasound are d

27 ic resonance imaging with magnetic resonance cholangiopancreatography and optional endoscopic ultraso

28 Timing of endoscopic retrograde cholangiopancreatography and outcome were stratified by

29 The combination of T2-weighted MR cholangiopancreatography and T1-weighted imaging yields

30 and endoscopic retrograde/magnetic resonance cholangiopancreatography and the lowest was 1.79% in stu

31 on with the results of endoscopic retrograde cholangiopancreatography and the secretin test.

32 hy, contrast material-enhanced MR imaging/MR cholangiopancreatography, and ASGE risk stratification g

33 ography scan, ultrasound, magnetic resonance cholangiopancreatography, and direct cholangiography.

34 ical computed tomography, magnetic resonance cholangiopancreatography, and endoscopic ultrasonography

35 opic retrograde cholangiopancreatography, MR cholangiopancreatography, and fluoroscopy will be demons

36 minal trauma, surgery, endoscopic retrograde cholangiopancreatography, and gallstones.

37 , computed tomography, endoscopic retrograde cholangiopancreatography, and magnetic resonance imaging

38 for pancreatitis after endoscopic retrograde cholangiopancreatography, and refinements in photodynami

39 gnetic resonance imaging, magnetic resonance cholangiopancreatography, and/or endoscopic ultrasound.

40 ic ultrasonography and endoscopic retrograde cholangiopancreatography are just beginning to be assess

41 CT and MR cholangiopancreatography are the most common cross-secti

42 ng therapeutic role of endoscopic retrograde cholangiopancreatography as well as improvements in our

43 gations in therapeutic endoscopic retrograde cholangiopancreatography as well as knowledge gaps for f

44 of pancreatitis after endoscopic retrograde cholangiopancreatography as well as morbidity in the eld

45 undergoing therapeutic endoscopic retrograde cholangiopancreatography at university hospitals in Euro

46 on guidelines versus magnetic resonance (MR) cholangiopancreatography-based treatment of patients wit

47 Endoscopic retrograde cholangiopancreatography brushings were obtained from 49

48 that balloon-assisted endoscopic retrograde cholangiopancreatography can achieve papillary cannulati

49 MR cholangiopancreatography can depict congenital and acqui

50 iven immediately after endoscopic retrograde cholangiopancreatography can reduce the incidence of acu

51 any cases, therapeutic endoscopic retrograde cholangiopancreatography can take the place of invasive

52 uted tomography scans, endoscopic retrograde cholangiopancreatography, carcinoembryonic antigen, and

53 Endoscopic retrograde cholangiopancreatography confirmed the diagnosis and all

54 Pediatric endoscopic retrograde cholangiopancreatography continues to evolve, with incre

55 possible choledocholithiasis: noncontrast MR cholangiopancreatography, contrast material-enhanced MR

56 Sensitivities for T2-weighted MR cholangiopancreatography data alone were 0.65, 0.70, and

57 Timing of endoscopic retrograde cholangiopancreatography does not appear to affect clini

58 EST PRACTICE ADVICE 8: Endoscopic retrograde cholangiopancreatography during pregnancy may be perform

59 SC patients undergoing endoscopic retrograde cholangiopancreatography earlier in their clinical cours

60 Magnetic resonance cholangiopancreatography enables reliable diagnosis of c

61 software manipulation of magnetic resonance cholangiopancreatography, enabling preoperative VR explo

62 ctor computed tomography, magnetic resonance cholangiopancreatography, endoscopic ultrasonography, an

63 holecystectomies and 4 endoscopic retrograde cholangiopancreatography/endoscopic sphincterotomies (ER

64 ts undergoing elective endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasono

65 inical applications of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasoun

66 eviewed the results of endoscopic retrograde cholangiopancreatography (ERCP) and intraoperative chola

67 While endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhe

68 increased by previous endoscopic retrograde cholangiopancreatography (ERCP) and stent placement, and

69 typically managed with endoscopic retrograde cholangiopancreatography (ERCP) and stenting.

70 erforations related to endoscopic retrograde cholangiopancreatography (ERCP) are rare but life-threat

71 e scheduled to undergo endoscopic retrograde cholangiopancreatography (ERCP) between March 26, 2008,

72 MRCP obviated endoscopic retrograde cholangiopancreatography (ERCP) by excluding choledochol

73 transmission following endoscopic retrograde cholangiopancreatography (ERCP) can occur due to persist

74 biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) can result in failure of

75 th cholangioscopes and endoscopic retrograde cholangiopancreatography (ERCP) catheters.

76 contrast agents during endoscopic retrograde cholangiopancreatography (ERCP) causes pancreatic inflam

77 nostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP) continues to mature.

78 sy and others, such as endoscopic retrograde cholangiopancreatography (ERCP) cytology, are problemati

79 logy/surgical findings/Endoscopic Retrograde CholangioPancreatography (ERCP) findings as applicable.

80 ADVICE 2: The role of endoscopic retrograde cholangiopancreatography (ERCP) for reducing the frequen

81 aphy (EUS) may replace endoscopic retrograde cholangiopancreatography (ERCP) for the detection of CBD

82 ver the past 50 years, endoscopic retrograde cholangiopancreatography (ERCP) has become the preferred

83 mples were obtained at endoscopic retrograde cholangiopancreatography (ERCP) in 59 patients with gall

84 of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients, t

85 ent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients.

86 tent utilized at index endoscopic retrograde cholangiopancreatography (ERCP) in management of maligna

87 he experience of using endoscopic retrograde cholangiopancreatography (ERCP) in the management of hep

88 on the performance of endoscopic retrograde cholangiopancreatography (ERCP) in the United States.

89 opy allows therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in these patients, avoid

90 Endoscopic retrograde cholangiopancreatography (ERCP) is a technically challen

91 Endoscopic retrograde cholangiopancreatography (ERCP) is a technically demandi

92 Endoscopic retrograde cholangiopancreatography (ERCP) is a widely utilized pro

93 Endoscopic retrograde cholangiopancreatography (ERCP) is important in the mana

94 Preoperative endoscopic retrograde cholangiopancreatography (ERCP) is only useful for patie

95 rmed endoscopically by endoscopic retrograde cholangiopancreatography (ERCP) or by percutaneous trans

96 evaluated by means of endoscopic retrograde cholangiopancreatography (ERCP) or magnetic resonance ch

97 om ductal drainage via endoscopic retrograde cholangiopancreatography (ERCP) or surgical drainage pro

98 the prevention of postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.

99 verticulum (PAD) among endoscopic retrograde cholangiopancreatography (ERCP) patients in Southwestern

100 Endoscopic retrograde cholangiopancreatography (ERCP) plays a significant role

101 d duodenoscopes during endoscopic retrograde cholangiopancreatography (ERCP) procedures.

102 were time to surgery, endoscopic retrograde cholangiopancreatography (ERCP) rates, and postoperative

103 h PSC established with endoscopic retrograde cholangiopancreatography (ERCP) were compared with the M

104 agement often involves endoscopic retrograde cholangiopancreatography (ERCP) with manometry and sphin

105 Endoscopic retrograde cholangiopancreatography (ERCP) with or without sphincte

106 cholithiasis requiring endoscopic retrograde cholangiopancreatography (ERCP) with stone extraction re

107 phy (US), 21 patients; endoscopic retrograde cholangiopancreatography (ERCP), 19 patients; and percut

108 perforation related to endoscopic retrograde cholangiopancreatography (ERCP), a rate of 1.0%.

109 ding, judicious use of endoscopic retrograde cholangiopancreatography (ERCP), and gallbladder surgery

110 sk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), based on findings from

111 ated and compared with endoscopic retrograde cholangiopancreatography (ERCP), clinical examination, a

112 hospitalization after endoscopic retrograde cholangiopancreatography (ERCP), largely for the evaluat

113 e to humans through an endoscopic retrograde cholangiopancreatography (ERCP), may offer a potential i

114 idental finding during endoscopic retrograde cholangiopancreatography (ERCP), occurring more frequent

115 made with findings at endoscopic retrograde cholangiopancreatography (ERCP), performed within 30 day

116 common complication of endoscopic retrograde cholangiopancreatography (ERCP), resulting in substantia

117 the 2-stage approach [endoscopic retrograde cholangiopancreatography (ERCP), sphincterotomy, and com

118 copic ultrasonography, endoscopic retrograde cholangiopancreatography (ERCP), spiral computed tomogra

119 Endoscopic retrograde cholangiopancreatography (ERCP), the most commonly perfo

120 eared complications of endoscopic retrograde cholangiopancreatography (ERCP), with an incidence of 3.

121 Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events (

122 SC patients undergoing endoscopic retrograde cholangiopancreatography (ERCP).

123 of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

124 uracy when compared to endoscopic retrograde cholangiopancreatography (ERCP).

125 need for preoperative endoscopic retrograde cholangiopancreatography (ERCP).

126 scopic) have undergone endoscopic retrograde cholangiopancreatography (ERCP).

127 was pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

128 holithiasis to receive endoscopic retrograde cholangiopancreatography (ERCP).

129 of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

130 of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

131 jor complication after endoscopic retrograde cholangiopancreatography (ERCP).

132 nostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

133 initiating therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

134 st current therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

135 of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

136 sover rate, numbers of endoscopic retrograde cholangiopancreatography (ERCPs) and stents, and stent-

137 copic ultrasonography and magnetic resonance cholangiopancreatography extend the diagnostic power of

138 patients had undergone endoscopic retrograde cholangiopancreatography for attempted relief in the pas

139 patients who underwent endoscopic retrograde cholangiopancreatography for evaluation of malignancy at

140 re destined to replace endoscopic retrograde cholangiopancreatography for many diagnostic indications

141 ve patients undergoing endoscopic retrograde cholangiopancreatography for pancreatobiliary strictures

142 the latest findings on endoscopic retrograde cholangiopancreatography for the evaluation of biliary s

143 Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks).

144 Patients who had an endoscopic retrograde cholangiopancreatography had fewer recurrent biliary eve

145 duodenoscopes used for endoscopic retrograde cholangiopancreatography have highlighted the challenge

146 endoscopic ultrasound and magnetic resonance cholangiopancreatography in chronic pancreatitis diagnos

147 ) correlates well with endoscopic retrograde cholangiopancreatography in moderate to severe chronic p

148 and the performance of endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y gast

149 biliary biopsy) during endoscopic retrograde cholangiopancreatography in the absence of an alternativ

150 arly feeding, avoiding endoscopic retrograde cholangiopancreatography in the absence of concomitant c

151 s the diagnostic value of magnetic resonance cholangiopancreatography in the diagnostics of biliary d

152 endoscopic ultrasound and magnetic resonance cholangiopancreatography in the evaluation of suspected

153 Patients underwent 1.5-T MR cholangiopancreatography, including DW sequences (b = 0,

154 All subjects underwent 3.0-T MR cholangiopancreatography, including serial DW imaging se

155 Endoscopic retrograde cholangiopancreatography-induced acute pancreatitis can

156 at diclofenac prevents endoscopic retrograde cholangiopancreatography-induced pancreatitis.

157 ation recommending endoscopy (high risk), MR cholangiopancreatography (intermediate risk), or no test

158 Magnetic resonance cholangiopancreatography is a cost-effective and accurat

159 Endoscopic retrograde cholangiopancreatography is a non-surgical approach to d

160 Magnetic resonance imaging with contrast and cholangiopancreatography is a reasonable complementary o

161 Magnetic resonance cholangiopancreatography is a relatively noninvasive tec

162 Endoscopic retrograde cholangiopancreatography is commonly performed to remove

163 o be overlooked unless endoscopic retrograde cholangiopancreatography is performed.

164 Endoscopic retrograde cholangiopancreatography is reserved primarily for thera

165 MRI with magnetic resonance cholangiopancreatography is the preferred imaging modali

166 phy, magnetic resonance (MR) imaging, and MR cholangiopancreatography, is increasing, and many of the

167 server agreement was good for T2-weighted MR cholangiopancreatography (kappa for readers 1 and 2 = 0.

168 s were correlated with endoscopic retrograde cholangiopancreatography, laboratory parameters, and fib

169 Advancements in the endoscopic retrograde cholangiopancreatography medical literature in the last

170 Endoscopic retrograde cholangiopancreatography mitigates this risk and should

171 esonance (MR) imaging, endoscopic retrograde cholangiopancreatography, MR cholangiopancreatography, a

172 uted tomography scanning, magnetic resonance cholangiopancreatography (MRCP) and positron emission to

173 Magnetic resonance cholangiopancreatography (MRCP) is the best test to eval

174 n the study who underwent magnetic resonance cholangiopancreatography (MRCP) studies.

175 concern in Nigeria, where magnetic resonance cholangiopancreatography (MRCP), a non-invasive imaging

176 inal ultrasound, CT, MRI, magnetic resonance cholangiopancreatography (MRCP), and T-tube cholangiogra

177 pancreatic ducts at magnetic resonance (MR) cholangiopancreatography (MRCP), because of an enlargeme

178 nts; magnetic resonance (MR) imaging with MR cholangiopancreatography (MRCP), four patients; endoscop

179 pancreatography (ERCP) or magnetic resonance cholangiopancreatography (MRCP).

180 the pancreatic duct with magnetic resonance cholangiopancreatography (MRCP).

181 tic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP), are helpful in the

182 Subsequently, combined MRI and MR cholangiopancreatography of the abdomen was performed wi

183 Subsequently, combined MRI and MR cholangiopancreatography of the abdomen was performed wi

184 he effect of timing of endoscopic retrograde cholangiopancreatography on clinical outcomes, and compa

185 P = .01), preoperative endoscopic retrograde cholangiopancreatography (OR, 2.07 [95% CI, 1.46-2.92];

186 the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis (ERCP) has been di

187 risk of developing postendoscopic retrograde cholangiopancreatography pancreatitis in high-risk peopl

188 the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

189 Enteroscopy-based endoscopic retrograde cholangiopancreatography, percutaneous transhepatic chol

190 experienced hands, and endoscopic retrograde cholangiopancreatography plays a diagnostic as well as t

191 MR cholangiopancreatography plays an important role in the

192 rs 1 and 3 = 0.734) and was excellent for MR cholangiopancreatography plus T1-weighted images (kappa

193 MR cholangiopancreatography alone and for MR cholangiopancreatography plus T1-weighted images were hi

194 pancreatitis following endoscopic retrograde cholangiopancreatography presents a unique opportunity f

195 EMS) may require fewer endoscopic retrograde cholangiopancreatography procedures (ERCPs) to achieve r

196 course of 40 weeks via endoscopic retrograde cholangiopancreatography procedures at a single institut

197 minations, and 169,500 endoscopic retrograde cholangiopancreatography procedures were performed annua

198 r tissue analysis, and endoscopic retrograde cholangiopancreatography provided access for dilation, s

199 e biliary obstruction likely benefit from MR cholangiopancreatography rather than risk-stratified dia

200 versus noncontrast and contrast-enhanced MR cholangiopancreatography, respectively, but was also les

201 cohol), gallstones, or endoscopic retrograde cholangiopancreatography result in a cascade of events b

202 mpared with pathology and magnetic resonance cholangiopancreatography results.

203 The results of endoscopic retrograde cholangiopancreatography served as the reference standar

204 Ideally, endoscopic retrograde cholangiopancreatography should be performed during the

205 The bundle states that endoscopic retrograde cholangiopancreatography should be performed within the

206 underwent preoperative endoscopic retrograde cholangiopancreatography since the isolated microorganis

207 ase, MRI, Primary Sclerosing Cholangitis, MR Cholangiopancreatography Supplemental material is availa

208 ce the introduction of endoscopic retrograde cholangiopancreatography, there have been great improvem

209 incremental cost per QALY for noncontrast MR cholangiopancreatography was $10 311.

210 Results Noncontrast MR cholangiopancreatography was most cost-effective in 45-5

211 tion cohort, timing of endoscopic retrograde cholangiopancreatography was not significantly different

212 MR cholangiopancreatography was performed in 37 consecutive

213 Initially, endoscopic retrograde cholangiopancreatography was purely a diagnostic procedu

214 MR cholangiopancreatography was successful in all patients.

215 or lipase levels, and endoscopic retrograde cholangiopancreatography was the method of diagnosis of

216 ed and/or known CP who were scheduled for MR cholangiopancreatography, were recruited and gave writte

217 gnostic utilization of endoscopic retrograde cholangiopancreatography which is now reserved primarily

218 essitating an emergent endoscopic retrograde cholangiopancreatography with biliary stenting and decom

219 our hospital where an endoscopic retrograde cholangiopancreatography with biliary stenting was perfo

220 lithiasis treated with endoscopic retrograde cholangiopancreatography with laparoscopic cholecystecto

221 a randomized trial of endoscopic retrograde cholangiopancreatography with SOM for patients with idio

222 k-stratified testing was less costly than MR cholangiopancreatography, with long-term savings of $187

223 stones, postoperative endoscopic retrograde cholangiopancreatography, wound infection, reoperation,